A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...
Fitgurú on MSN
This common diet mistake is physically severing the connection between your gut and brain, study finds
A groundbreaking analysis reveals that chronic consumption of fatty foods triggers a biological disconnect, flooding your gut ...
Researchers at Washington State University have uncovered evidence that sleep may not be entirely a function of the brain but also the microbes living within us. They discovered that bacterial cell ...
True or False: A large observational study found that adults with diabetes who used GLP-1 receptor agonists had more ...
Recent experimental findings suggest that d-amphetamine, a potent central nervous system stimulant, can override learned ...
News-Medical.Net on MSN
SN101 iPSC-derived therapy relieves chronic pain and preserves joints
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on ...
Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at INR 8,800 a month or four ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...
Eli Lilly leads incretins via Zepbound/Mounjaro, retatrutide at 28.7% loss, $50B R&D and US buildout, 2025 guidance, ...
As of Friday, December 12, Lantheus Holdings, Inc.’s LNTH share price has surged by 5.44%, which has investors questioning if this is right time to sell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback